Krysta Moulton

Krysta Moulton has extensive experience in financial leadership within the healthcare and biotechnology sectors. Currently serving as the Healthcare and Biotechnology Division Lead and Controller at Burkland since March 2023, Moulton also holds the position of Chief Financial Officer and Board Member at Alexis Bio. Previous roles include Consultant at Rios Partners, Chief Financial Officer at XenoTherapeutics Inc, and Chief Financial Officer at Boston Translational. Moulton's career began with a focus on operations and finance, with a degree in Political Science and Government from Harvard University and a Master of Science in Accounting from Southern New Hampshire University.